Fundraising Fox

Logos

Crossover fundActively deploying

San Francisco · Series A–Series B · 15 people tracked

Also known as LOGOS GLOBAL MANAGEMENT, L.P. · Logos Odin

Fox Verdict
Sign up to see your fit

Investment thesis

Logos Capital invests in biotechnology with a disciplined, data-driven and research-intensive approach, aiming to identify transformative, first-in-class and best-in-class therapeutics at attractive valuations. Recognizing that success in biotech requires more than science, the firm integrates clinical underwriting, continuous event tracking, and proactive risk management to assess intrinsic value across clinical, operational, regulatory, and commercial dimensions. It targets technologies that advance patient care through functional cures, improved access, and extended life expectancy. A proprietary data science platform, Logos Analytics, supports evaluation of trial design and probability of clinical success, with the primary mandate of delivering strong long-term returns to investors.

Invests inBiotechDigital HealthHealthtechNew YorkSan FranciscoUnited States

Source: firm website, verified Aug 3, 2026.

Stage
Series A–Series B
HQ
San Francisco, California, US
Instruments
Equity
Founded
2019
AUM
$2.3B
Tracked investments
1

Team · 15 people

from the firm's website & public directories
Dr. Arsani William· Managing Partner / Chief Investment Officer
Dr. Graham Walmsley· Managing Partner
Dr. Ed Zhong· Investment Advisor
Dr. Jesse Yu· Senior Analyst
Dr. Yuqi Wang· Senior Analyst
Ed Zhong· Investment Advisor

Investment Advisor at Logos Capital with a PhD.

Jesse Yu· Senior Analyst

Senior Analyst at Logos Capital with a PhD.

Yuqi Wang· Senior Analyst

Senior Analyst at Logos Capital with a PhD.

What they invest in

from 1 of 1 portfolio companies

Biotech ×1

HQs:China×1

Investments · 1 tracked

founders shown can be your intro path
NiKang Therapeuticsnikangtx.com

NiKang Therapeutics is a clinical-stage biotech company developing small molecule drugs for cancer treatment, focusing on HIF2α, CDK2, and KRAS targets using structure-based drug design.

Biotech

Frequently asked questions

What stage does Logos invest at?
Logos invests at the Series A, Series B stages.
What sectors does Logos focus on?
Logos focuses on Biotech, Digital Health, Healthtech.
Where is Logos located?
Logos is headquartered in San Francisco, US.

Images

Logos photoLogos photoLogos photoLogos photoLogos photoLogos photo

Similar investors

Featured in lists